Braving the Element: Pancreatic β-Cell Dysfunction and Adaptation in Response to Arsenic Exposure

Area of Science:

• Endocrinology
• Toxicology
• Metabolic disease research

Background:

• Type 2 diabetes mellitus (T2DM) affects over 451 million globally, characterized by hyperglycemia and impaired insulin function.
• T2DM arises from insulin resistance and insufficient insulin secretion, leading to pancreatic beta-cell failure.
• Beta-cell stress, oxidative damage, inflammation, and ER stress contribute to T2DM progression.

Purpose of the Study:

• To review the mechanisms by which inorganic arsenic (iAs) affects pancreatic beta-cell function and survival.
• To explore the link between iAs exposure and the development of T2DM.
• To understand how iAs influences pathways related to insulin resistance and beta-cell adaptation.

Main Methods:

• Literature review of epidemiological studies and mechanistic research on iAs and T2DM.
• Analysis of pathways involved in beta-cell stress, insulin resistance, and endocrine disruption.
• Focus on the role of exogenous bioactive compounds, specifically iAs, in metabolic dysfunction.

Main Results:

• Epidemiological studies show a significant correlation between iAs exposure and T2DM prevalence.
• iAs is proposed to exacerbate insulin resistance and impair beta-cell function and survival.
• Mechanisms involve iAs impacting pathways controlling beta-cell adaptation and survival.

Conclusions:

• Inorganic arsenic exposure is a potential environmental factor contributing to T2DM development.
• Understanding iAs mechanisms in beta cells is crucial for T2DM prevention and treatment strategies.
• Further research is needed to elucidate the precise molecular interactions between iAs and pancreatic beta cells.